Seven unanswered questions about blockbuster weight-loss drugs
Nature Medicine asks experts to explain the research priorities for the field of GLP-1 receptor agonists such as semaglutide, from sex differences to how they might treat addiction.
Nature Medicine asks experts to explain the research priorities for the field of GLP-1 receptor agonists such as semaglutide, from sex differences to how they might treat addiction.
In a cluster analysis study, we identified two types of metabolic dysfunction-associated steatotic liver disease (MASLD) characterized by distinct clinical trajectories. The two types of MASLD show similar liver histology, but one is liver-specific with low cardiovascular risk while the other has high cardiovascular risk and high metabolic risk.